NUDT1 and neoplasm: The ROS‐sensitive MTH1 gene knockdown by the CRISPR‐Cas9 system significantly enhanced the therapeutic effect of SDT via sensitizing tumor cells to SDT and hindered the self‐healing function of tumor cells.